The similarity in P-selectin levels between AF and noAF patients suggests that although both populations of patients have activated circulating platelets due to the presence of vascular risk factors, as they are both higher than P-selectin exposure of healthy donors, AF patients' platelets may be subject to other factors that separately cause GPVI dimerization, such as inflammation.21 The gene discussed is GP6; the disease is atrial fibrillation.